AusPAR: Mepolizumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Mepolizumab (rch) [PDF, 820.96 KB]

AusPAR: Mepolizumab (rch) [Word, 992.9 KB]

Product Information: Mepolizumab (rch) [PDF, 207.91 KB]

Product Information: Mepolizumab (rch) [Word, 100.62 KB]

Extract from Clinical Evaluation Report: Mepolizumab (rch) [PDF, 4.9 MB]

Extract from Clinical Evaluation Report: Mepolizumab (rch) [Word, 18.14 MB]

Device/Product Name

Nucala

Active ingredients

Mepolizumab (rch)

AusPAR Date

8 March 2017

Published

5 April 2017

Submission Number

PM-2014-03872-1-5

Submission Type

New biological entity

Decision

Approved